ERBB2 and metastatic malignant neoplasm in the lymph nodes: The high expression of CST1 remained its prognostic value in predicting worse OS and DFS in most of abovementioned subgroups such as tumor size, tumor differentiation, lymph node metastasis positive, ER/PR status, HER2 negative, TNM staging III, and histologic grade (Table S2).